Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo

Drug giant Bristol-Myers Squibb is partnering with Illumina, the leading maker of DNA sequencing gear, to develop diagnostic tests that will pair with Bristol's cancer drugs.